Skip to main content
Clinical Trials/CTRI/2024/06/069653
CTRI/2024/06/069653
Not yet recruiting
Phase 3

Efficacy of topical heparin in preventing superficial thrombophlebitis after peripheral intravenous cannulation: A placebo controlled randomized trial - NI

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I809- Phlebitis and thrombophlebitis ofunspecified site
Sponsor
All India Institute of Medical Sciences, Mangalagiri
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Children aged 1 month\-14 years admitted in inpatient department requiring IV cannulation for at least 72 hours
  • 2\.Parents who have given written informed consent

Exclusion Criteria

  • Children who required iv access in the last 28 days, have hypersensitivity to heparin, have any condition which has procoagulant tendency, already on anticoagulant therapy or planned for anti coagulant therapy, already on non\-steroidal anti\-inflammataory drugs or planned for non\-steroidal anti\-inflammataory drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials